Clinical Study
An Appraisal of Anatomical and Limited Hepatectomy for Regional Hepatolithiasis
Table 1
Characteristics of patients with regional hepatolithiasis treated by limited hepatectomy (LH) or anatomical hepatectomy (AH).
| Variable | LH Group () | AH Group () | Value |
| Sex (male/female) | 21/38 | 14/33 | .528 | Age (year) | 57.7 ± 1.2 | 59 ± 0.8 | .453 |
| Comorbidities | | | | Ischemic heart disease | 9 | 7 | .959 | Diabetes | 11 | 6 | .413 | Chronic obstructive airway disease | 3 | 1 | .779 | Cirrhosis | 5 | 2 | .635 |
| Laboratory test | | | | Serum bilirubin (umol/L) | 34.3 ± 9.1 | 43.6 ± 4.7 | .188 | Serum albumin (g/L) | 41.3 ± 2.6 | 42.0 ± 1.9 | .403 | Alanine transaminase (U/L) | 80.7 ± 11.3 | 93.4 ± 9.8 | .805 | Aspartate transaminase (U/L) | 77.8 ± 13.0 | 101.3 ± 3.7 | .739 | Alkaline phosphatase (U/L) | 189.9 ± 26.2 | 217.2 ± 13.9 | .225 | r-Glutamyl transferase (U/L) | 139.4 ± 11.2 | 151.8 ± 10.7 | .442 | Hemoglobin (g/dL) | 11.8 ± 0.9 | 11.7 ± 1.6 | .558 | Platelet count (109/L) | 271 ± 13.0 | 275 ± 17.6 | .904 | White blood cell count (109/L) | 10.4 ± 0.4 | 10.9 ± 0.8 | .670 | Neutrophil (%) | 79 ± 9.2 | 77 ± 8.6 | .790 | Prothrombin time (s) | 14.3 ± 0.6 | 13.6 ± 1.3 | .931 | APTT (s) | 31.8 ± 1.4 | 31.9 ± 1.8 | .392 | Serum hepatitis B surface antigen (positive/negative) | 11/48 | 8/39 | 1.000 | Indocyanine green clearance (%) | 9.3 ± 0.9 | 8.3 ± 1.7 | .172 | Glucose (mmol/L) | 7.4 ± 1.4 | 8.2 ± 0.9 | .724 |
|
|